Updated July 2026 · 7 min read

Methemoglobinemia for ICU Nurses 2026 — Blue Patient, Normal PaO2, No Response to Oxygen

Part of the ICU Emergencies Hub — browse every related guide in one place.

Every so often a patient turns dusky and cyanotic, the pulse oximeter reads low and stubborn, and yet the arterial blood gas shows a perfectly good PaO2. Cranking up the oxygen does nothing. That mismatch — a blue patient who won't pink up despite an adequate PaO2 — is the fingerprint of methemoglobinemia, where the hemoglobin itself has been chemically altered so it can't carry or release oxygen normally. This guide explains what's happening in the blood, the drugs that cause it, why the monitors lie, and how methylene blue turns it around.

What's actually wrong with the blood

Hemoglobin carries oxygen only when its iron is in the ferrous state. When an oxidizing drug or toxin flips that iron to the ferric state, that hemoglobin becomes methemoglobin, which cannot bind oxygen at all. Worse, its presence shifts the remaining normal hemoglobin so it clings to its oxygen more tightly and unloads less to the tissues. So there are two hits: less carrying capacity and poorer delivery. The body normally keeps a tiny amount of methemoglobin around and reduces it back with an enzyme system, but a big oxidant exposure overwhelms that, and the level climbs. As it rises, the patient goes from looking dusky, to symptomatic with headache and fatigue, to acidotic and obtunded at high levels, with life-threatening compromise as it approaches the severe range.

Why the monitors lie

This is the part every ICU nurse should internalize. A standard two-wavelength pulse oximeter is fooled by methemoglobin and tends to drift toward a reading in the mid-80s no matter the true oxygenation — it neither rises with oxygen nor tracks the real severity. Meanwhile the arterial blood gas measures dissolved oxygen (PaO2), which is normal because the lungs are fine; it's the hemoglobin that's broken, not the gas exchange. The calculated saturation on the gas may look reassuring while the patient is genuinely hypoxic at the tissue level. The tool that tells the truth is co-oximetry, which measures the methemoglobin fraction directly. The visual tell at the bedside is the blood: it draws back dark, chocolate-brown, and doesn't turn red on exposure to air.

What triggers it

Most ICU cases are drug-induced. The frequent offenders are topical and local anesthetics — especially benzocaine sprays used before procedures like TEE or intubation, and prilocaine — along with dapsone, certain nitrates and nitrites, and some antimalarials and aniline dyes. A patient who becomes cyanotic shortly after a benzocaine spray for an airway or endoscopy procedure is a classic scenario, and it's one the nurse may witness in real time. Recognizing the temporal link between an oxidizing drug and sudden refractory “desaturation” is often what cracks the case.

The antidote — and the G6PD trap

The specific treatment for significant or symptomatic methemoglobinemia is methylene blue, which supercharges an alternate pathway that reduces the iron back to its oxygen-carrying state, and the response can be dramatic. Supportive oxygen is given but won't fix the underlying problem, and the trigger must be removed. The crucial caution the nurse should know: in patients with G6PD deficiency, methylene blue may be ineffective and can actually precipitate hemolysis, so it's used with great care or avoided, and alternative approaches are considered. It's also worth knowing that methylene blue itself will transiently throw off the pulse oximeter and can tint urine and secretions blue-green — expected, not alarming.

The nursing bottom line

Methemoglobinemia is a chemical problem with the hemoglobin, not the lungs: oxidized iron can't carry oxygen and won't release what little it holds, so the patient looks blue while the PaO2 stays normal — the saturation gap. Standard pulse oximetry is unreliable and hovers in the mid-80s; co-oximetry gives the real methemoglobin level, and chocolate-brown blood is the bedside tell. The usual triggers are oxidizing drugs, with benzocaine and other local anesthetics, dapsone, and nitrates leading the list. Methylene blue is the antidote, given cautiously or avoided in G6PD deficiency. The nurse's contribution is pattern recognition: a cyanotic patient who won't respond to oxygen after an oxidant exposure needs co-oximetry, not just a higher FiO2.

Related: Carbon monoxide poisoning · Cyanide poisoning · Capnography & EtCO2 · ABG interpretation

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.